Functional relevance of neurotransmitter receptor heteromers in the central nervous system

被引:118
作者
Ferre, Sergi [1 ]
Ciruela, Francisco
Woods, Amina S.
Lluis, Carme
Franco, Rafael
机构
[1] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Natl Inst Hlth,Dept Hlth & Human Serv, Baltimore, MD 21224 USA
[2] Univ Barcelona, Fac Biol, Inst Invest Biomed August Pi I Sunyer, E-08028 Barcelona, Spain
[3] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
关键词
D O I
10.1016/j.tins.2007.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The existence of neurotransmitter receptor heteromers is becoming broadly accepted and their functional significance is being revealed. Heteromerization of neurotransmitter receptors produces functional entities that possess different biochemical characteristics with respect to the individual components of the heteromer. Neurotransmitter receptor heteromers can function as processors of computations that modulate cell signaling. Thus, the quantitative or qualitative aspects of the signaling generated by stimulation of any of the individual receptor units in the heteromer are different from those obtained during coactivation. Furthermore, recent studies demonstrate that some neurotransmitter receptor heteromers can exert an effect as processors of computations that directly modulate both pre- and postsynaptic neurotransmission. This is illustrated by the analysis of striatal receptor heteromers that control striatal glutarnatergic neurotransmission.
引用
收藏
页码:440 / 446
页数:7
相关论文
共 54 条
[1]   Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons [J].
Agnati, LF ;
Ferré, S ;
Lluis, C ;
Franco, R ;
Fuxe, K .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :509-550
[2]   How receptor mosaics decode transmitter signals.: Possible relevance of cooperativity [J].
Agnati, LF ;
Fuxe, K ;
Ferré, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (04) :188-193
[3]   The GDNF family: Signalling, biological functions and therapeutic value [J].
Airaksinen, MS ;
Saarma, M .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (05) :383-394
[4]   Guide to Receptors and Channels, 2nd edition (2007 Revision) [J].
Alexander, Stephen P. H. ;
Mathie, Alistair ;
Peters, John A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 :S1-S168
[5]   Lipid raft microdomains and neurotransmitter signalling [J].
Allen, John A. ;
Halverson-Tamboli, Robyn A. ;
Rasenick, Mark M. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (02) :128-140
[6]  
Barnard EA, 1998, PHARMACOL REV, V50, P291
[7]   GPCR interacting proteins (GIP) [J].
Bockaert, J ;
Fagni, L ;
Dumuis, A ;
Marin, P .
PHARMACOLOGY & THERAPEUTICS, 2004, 103 (03) :203-221
[8]   Oligomerization of G-protein-coupled transmitter receptors [J].
Bouvier, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (04) :274-286
[9]   Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer [J].
Canals, M ;
Marcellino, D ;
Fanelli, F ;
Ciruela, F ;
de Benedetti, P ;
Goldberg, SR ;
Neve, K ;
Fuxe, K ;
Agnati, LF ;
Woods, AS ;
Ferré, S ;
Lluis, C ;
Bouvier, M ;
Franco, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46741-46749
[10]  
CARRIBA P, 2007, NEUROPSYCHOPHARMACOL